Alector, Inc. (ALEC)
1.87
-0.03
(-1.58%)
USD |
NASDAQ |
Feb 13, 16:00
1.88
+0.01
(+0.53%)
After-Hours: 20:00
Alector EPS Diluted (Quarterly) : -0.3379 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vistagen Therapeutics, Inc. | -0.4475 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -34.67M |
| Revenue (Quarterly) | 3.26M |
| Total Expenses (Quarterly) | 37.93M |
| Enterprise Value | -49.12M |
| Gross Profit Margin (Quarterly) | 28.47% |
| Profit Margin (Quarterly) | -1.06K% |
| Earnings Yield | -57.24% |
| Normalized Earnings Yield | -56.43 |